News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Shire plc Ups Headcount Despite Takeover Rumors


6/10/2013 8:22:24 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Flemming Ornskov, who took over as Shire Plc (SHP)’s chief executive officer six weeks ago, is adding sales jobs and eschewing future share buybacks while cooling speculation that the drugmaker is an imminent takeover target. Shire cut its U.S. sales force by as much as 150 last year, and Ornskov said he expects to restore a “significant” portion of those jobs in anticipation of widening use for Vyvanse, the company’s top-selling drug for attention deficit hyperactivity disorder, as a therapy for binge-eating and depression. Ornskov said he has no plans to expand a share-repurchasing program started by his predecessor, Angus Russell, who retired in April after 13 years at the company.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg


comments powered by Disqus
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES